Nalu Bio is a female-founded and led San Francisco-based biotech company committed to accelerating the potential of cannabinoids for the health of people and the planet. Nalu Bio is harnessing the power of chemistry and predictive AI modeling to solve the world's top health and wellness challenges impacting 2 billion people globally, including pain, anxiety, sleep, and weight loss. Our proprietary pipeline of no-high, chemistry-derived cannabinoids for global CPG and therapeutics companies maintain the molecular identity of the plant while addressing the drawbacks, including safety, predictability, scalability, and sustainability. Nalu Bio offers minor cannabinoids and combinations with bioactives to provide effective, safe, and consistent products for food and beverage, health and wellness, and personal care. Additionally, our pipeline of therapeutic products mimics naturally occurring cannabinoids to develop new chemicalentities (NCEs). This approach aims to increase druggability, safety, and efficacy while potentially reducing side effects in some of the most in-demand medications on the market. Learn more at NaluBio.com and contact us at hello@nalubio.com.